The Central Drugs Standard Control Organisation (CDSCO) issued an advisory on 21 September 2026, signed by DCGI Dr Rajeev Singh Raghuvanshi, calling for the rational use of NSAID painkillers and antibiotics.
It warns that indiscriminate or prolonged NSAID use without medical supervision can damage the kidneys and cause or worsen chronic kidney disease (CKD); antibiotic misuse drives antimicrobial resistance (AMR).
Chemists must strictly follow the rules on selling Schedule H and H1 drugs and must not encourage self-medication; doctors should prescribe the lowest effective NSAID dose for the shortest appropriate duration.
Parent law for the manufacture, sale, import and distribution of drugs; CDSCO discharges the Central Government's functions under it.
Cited in the advisory; prescribes the labelling and caution requirements for prescription-only drugs.
Prescription-only drugs to be sold only on the prescription of a Registered Medical Practitioner; covers most NSAIDs.
Added for certain newer antibiotics, anti-TB drugs and habit-forming drugs; in force from 1 March 2014; the chemist must keep a separate register of each sale.
India's National Regulatory Authority for drugs, medical devices and cosmetics: approves new drugs and clinical trials, sets drug standards, controls imports, coordinates State drug controllers
License and inspect retail and wholesale chemists; enforce Schedule H/H1 sale rules on the ground
Stop the over-the-counter sale of antibiotics
Key: A red vertical line on the packs of prescription-only antibiotics, telling buyers not to take them without a doctor's prescription
India's first national plan against antimicrobial resistance, aligned with the WHO Global Action Plan
Key: One Health approach across human, animal and environmental sectors
Five-year roadmap (2025-2029) to contain antimicrobial resistance
Key: Launched by Union Health Minister J.P. Nadda during World AMR Awareness Week
Schedule H1 notified under the Drugs and Cosmetics Rules
Schedule H1 comes into force
Health Ministry launches the Red Line campaign on antibiotics
First National Action Plan on AMR (2017-2021)
NAP-AMR 2.0 (2025-2029) launched
CDSCO advisory on rational use of NSAIDs and antibiotics, citing CKD risk
GS Paper II > Health, statutory regulators; GS Paper III > Science and Technology > Antimicrobial resistance
General Awareness > Health / Government bodies
Non-steroidal anti-inflammatory drugs such as ibuprofen and diclofenac, used for pain and inflammation; overuse can harm the kidneys.
Coordinated steps to ensure antimicrobials are prescribed only when needed, in the right drug, dose and duration.
Stricter prescription-only list (in force from 1 March 2014) for certain antibiotics, anti-TB and habit-forming drugs, with a separate sale register.